Stockwinners Market Radar for March 28, 2022 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:07 EDT Cathie Wood's ARK Investment bought 43.6K shares of Monday.com today

20:05 EDT Cathie Wood's ARK Investment bought 62.9K shares of Coinbase today

19:34 EDT Poshmark director sells $2.66M in common stock - In a regulatory filing, Poshmark disclosed that its director Hans Tung sold 196K shares of common stock on March 24th in a total transaction size of $2.66M.

19:01 EDT Western Union expands in South Korea with ICB - Western Union announced the launch of its money transfer services with ICB, a fintech company in South Korea, offering customers seamless access to Western Union's money transfer services via ICB's mobile app - DEBUNK Remit. DEBUNK Remit mobile app, available for Android and iOS, will enable senders from South Korea to send money to their loved ones for payout in cash and into bank accounts in select countries worldwide as a start, eventually scaling up to Western Union's global financial payout network. Senders can fund their transactions through their bank accounts registered with the DEBUNK Remit mobile app. The mobile app also enables receivers in South Korea to direct international Western Union money transfers into their DEBUNK Remit registered bank accounts, for transactions sent through Western Union's digital money transfer services or Western Union's worldwide retail Agent network. Receivers in South Korea can now receive the money by inputting the unique Money Transfer Control Number and other information into the DEBUNK Remit mobile app.

17:53 EDT Canada moves closer to delivering 88 Lockheed F-35 jets for RCAF - Canada's Ministry of Public Services and Procurement said the Government of Canada has reached another milestone in the competitive process to purchase 88 advanced fighter jets for the Royal Canadian Air Force, which will ensure the requirements of the RCAF are met while also providing value for Canadians, generating high-value jobs in Canada as well as further growth for the Canadian aerospace and defence sector for decades to come. "Following a rigorous evaluation of proposals, the Government of Canada today announced it will now enter into the finalization phase of the procurement process with the top-ranked bidder, the United States government and Lockheed Martin, for the F-35 fighter jet," the ministry said. "This procurement represents the most significant investment in the RCAF in more than 30 years. It is essential for protecting the safety and security of Canadians, it will enhance our Arctic sovereignty, it will ensure we are equipped to better defend North America and it will help make sure we continue to meet our NATO and NORAD obligations well into the future."

17:47 EDT Boyd Gaming to acquire Pala Interactive for $170M - Boyd Gaming announced that its wholly-owned subsidiary, Boyd Interactive Gaming, has entered into a definitive agreement to acquire Pala Interactive and its subsidiaries for total cash consideration of $170M. Pala Interactive is an online gaming technology company that provides proprietary real money and social gaming solutions on both a business-to-business and business-to-consumer basis in regulated markets across the United States and Canada. Pala Interactive's technology includes its player account management system; casino; poker and social casino and poker platforms. Pala currently provides B2B services in eight states across the United States as well as Canada, and operates B2C offerings in New Jersey and Canada. The transaction is expected to close by Q1 of 2023, subject to customary closing conditions and the receipt of all required regulatory approvals. The transaction will be financed with a combination of cash on hand and the company's existing credit agreement. Keith Smith, president and CEO of Boyd Gaming, said: "The acquisition of Pala Interactive marks the next phase in the ongoing execution of our iGaming strategy, providing us full control over the technology, development and customer experience. By integrating online casinos with our existing land-based operations, we will be able to further leverage and monetize our expansive customer database and the amenities of our nationwide portfolio of properties, driving growth in both our land-based and iGaming operations."

17:20 EDT Boeing awarded $122.72M Defense Logistics Agency contract - Boeing has been awarded a maximum $122.72M firm-fixed-price, fixed-quantity contract for KC-135 horizontal stabilizers. This was a sole-source acquisition using justification 10 U.S. Code 2304 as stated in Federal Acquisition Regulation 6.301-1. This is a six-year two-month contract with no option periods. Locations of performance are Missouri and Oklahoma, with an April 30, 2028, performance completion date. Using military service is Air Force. Type of appropriation is fiscal 2022 defense working capital funds. The contracting activity is the Defense Logistics Agency Aviation.

17:16 EDT LCI Industries unit acquires Girard Systems and Girard Products, no terms - LCI Industries announced that its subsidiary, Lippert Components Manufacturing, has acquired substantially all of the business assets of Girard Systems and Girard Products, a manufacturer and distributor of proprietary awnings and tankless water heaters for OEMs and aftermarket customers in the recreational vehicle, specialty vehicle, and related industries.

17:04 EDT Dave & Buster's falls about 7% to $40.08 after Q4 earnings miss

17:01 EDT Ball Corp. to reduce operations immediately at three factories in Russia - Ball Corporation released the following statement: "Ball Corporation continues to be deeply troubled by the war in Ukraine. In addition to suspending future investments in Russia-a decision we shared last week-we have made the decision to reduce operations immediately at our three manufacturing facilities in Russia and are pursuing the sale of our Russian business to a new owner. In 2021, our Russian business represented approximately 4 percent of the company's total net sales and 8 percent of the company's total comparable operating earnings. In addition, our plants in Russia produced approximately 5 percent of the company's 112.5 billion global beverage can unit shipments during 2021."

16:46 EDT AIG to rebrand SAFT Retirement Services as Corebridge Financial - American International Group announced that it plans to rebrand SAFG Retirement Services, Inc., the parent company of its Life & Retirement business, as Corebridge Financial, Inc. when it becomes a public company. "Today's announcement represents continued progress as we prepare our Life & Retirement business to be a standalone company," said Peter Zaffino, Chairman & CEO, AIG. "Our team of committed colleagues work hard every day to find solutions that allow people to take action and build a secure bridge to their financial futures," said Kevin Hogan, Executive Vice President and Chief Executive Officer of Life & Retirement. "As Corebridge, we will continue to proudly partner with financial and retirement professionals to help their clients feel confident and motivated today, and in control of their tomorrow."

16:41 EDT Norwood Financial announces James Donnelly as CEO - Norwood Financial announced that James Donnelly had accepted an offer to become president and CEO of the company, and its wholly owned subsidiary, Wayne Bank, effective upon his first day of employment with the company, anticipated to be in early May. Following his appointment as President and CEO, he will also be appointed as a member of the board of directors of the company and the bank. Lewis Critelli, current president and CEO of the company and bank previously announced his intention to retire during the first half of 2022, subject to the completion of a search process for a successor. Critelli intends to continue serving as a director of the company and bank upon his retirement as CEO. Donnelly joins the company with over 30 years of banking experience, most recently with Bangor Savings Bank where he served as its executive VP and chief commercial officer.

16:40 EDT NeoGenomics trading resumes

16:38 EDT Stratus Properties sale of Block 21 to Ryman to close prior to June 1 - Stratus Properties (STRS) announced that the anticipated closing date for the previously announced sale of Block 21 by Stratus to Ryman Hospitality (RHP) has been extended, as the parties complete the process of obtaining the remaining required approvals of the assumption of the property's existing mortgage loan by the purchaser. The acquisition is now expected to close sometime prior to June 1, subject to the timely satisfaction or waiver of various closing conditions, including the final consent of the loan servicers to the assumption of the existing loan by the purchaser, the consent of the hotel operator to the assumption of the hotel operating agreement by the purchaser, the absence of a material adverse effect, and other customary closing conditions. Block 21 is Stratus' wholly owned mixed-use development in downtown Austin, Texas, that contains the W Austin Hotel and office, retail and entertainment space, including the ACL Live at Moody Theater concert venue.

16:34 EDT Scorpio Tankers to collaborate on development of onboard carbon capture - Scorpio Tankers announced that the company has entered into a memorandum of understanding to collaborate on the development of onboard carbon capture for maritime vessels. Carbon Ridge is a U.S.-based startup working to commercialize existing gas separation technology without the need for large structural modifications. The agreement addresses the collaboration for detailed front-end engineering, design, and validation process with a small-scale test unit onboard one of the company's vessels.

16:32 EDT Murphy Oil concludes drilling at Cutthroat-1 exploration well offshore Brazil - Murphy Oil Corporation (MUR) announced that drilling has concluded at the Cutthroat-1 exploration well in block SEAL-M-428 in the Sergipe-Alagoas Basin offshore Brazil. While the presence of hydrocarbons was not found, the partner group will continue to integrate the exploration well data into its regional subsurface interpretation efforts in order to better understand the exploration potential of its deepwater blocks located in the Sergipe-Alagoas Basin. Cutthroat-1 is located nearly 90 kilometers offshore Brazil and was drilled in 3,094 meters of water by the Seadrill West Saturn drillship. It is one of multiple prospects that the partner group has mapped in the Sergipe-Alagoas Basin. ExxonMobil (XOM) is the operator and holds 50% working interest in 9 offshore SEAL blocks that spans over 6,800 square kilometers. Enauta Energia S.A. holds 30% working interest and Murphy Oil Corporation holds 20% working interest in the partnership.

16:31 EDT RGC Resources announces $21M investment from InterTech - RGC Resources closed today a $21M common stock investment by affiliates of The InterTech Group. Resources also closed an additional $2M common stock investment by long-time shareholder Ted Gibson.

16:27 EDT Ambarella hires new CFO, Brian White, formerly with Maxim Integrated Products - Ambarella (AMBA), announced that Brian White has joined the Company and will be appointed chief financial officer ( after filing its fiscal year 2022 Annual Report, which is estimated to be filed on April 1st. As CFO, Mr. White will report directly to Chief Executive Officer Fermi Wang. Mr. White brings more than 30 years of experience in finance, corporate strategy, business development and public accounting to Ambarella. Most recently, he was CFO at Maxim Integrated Products (MXIM) from August 2019 through its merger with Analog Devices (ADI) in August . Prior to that, he was CFO at Integrated Device Technology (IDT) for almost six years, where he drove significant improvements in financial results and value creation. Before his role as CFO, he served as IDT's treasurer and vice president of finance for six years. Mr. White has also held a variety of financial and operational management positions at companies including Nvidia, Hitachi GST, IBM and Deloitte. He holds a BA in Business Administration from Seattle University and an MBA from the University of Notre Dame.

16:24 EDT Raymond James to acquire SumRidge Partners, terms not disclosed - Raymond James Financial announced that it has reached an agreement to acquire SumRidge Partners, a top ranked, technology-driven fixed income market maker specializing in investment-grade and high-yield corporate bonds, municipal bonds and institutional preferred securities. The transaction is subject to certain regulatory and other closing conditions.

16:22 EDT Lightning eMotors expands partnership with Forest River - Lightning eMotors (ZEV) announced it has expanded its partnership with Forest River to offer a factory-certified all-electric repower program for shuttle buses and passenger vans. Forest River is a Berkshire Hathaway (BRK.A, BRK.B) company that manufactures shuttle buses, recreational vehicles, cargo trailers, utility trailers and pontoon boats, and is the dominant manufacturer of shuttle buses across U.S. and Canada. The Forest River factory-certified powertrains and installation will be backed by a five-year, 100,000-mile warranty. Additionally, Lightning Energy will provide Forest River dealers and customers with customized charging and microgrid energy solutions, including Lightning's Mobile Battery Vehicle Charging solutions to ensure customers have the necessary infrastructure to support fast ramp-up of their zero-emission fleets.

16:18 EDT Dice Therapeutics appoints Mary Riley as general counsel - Dice Therapeutics (DICE) announced the appointment of Mary Riley as general counsel. Riley joins Dice following a 15-year tenure at Genentech (RHHBY), most recently serving as vice president, litigation, where she served on the legal leadership team and was responsible for managing a wide range of legal matters.

16:15 EDT Boeing announces senior leadership changes - Boeing announced Ted Colbert as president and CEO of its Defense, Space and Security business. Colbert succeeds Leanne Caret who is retiring following nearly 35 years of exceptional service with The Boeing Company. Stephanie Pope has been appointed as president and CEO of Boeing Global Services, succeeding Colbert. As president and CEO of Boeing Global Services, Pope, who is currently Boeing Commercial Airplanes chief financial officer, will lead the company's business unit that provides aerospace services for commercial, government and aviation industry customers worldwide, focused on global supply chain and parts distribution, aircraft modifications and maintenance, digital solutions, aftermarket engineering, analytics and training. BGS had 2021 revenue of $16 billion. Prior to her assignment as BCA CFO, Pope was chief financial officer of BGS and was part of the business when it was established in 2017. Colbert and Pope's new assignments will be effective April 1. Until her retirement later this year, Caret will serve as executive vice president and senior advisor to the CEO, reporting to Calhoun, to support the leadership transition, business continuity and critical talent acquisition efforts.

16:15 EDT Cullinan provides update on CLN-081, anticipates initiation of a pivotal study - Cullinan Oncology announced clinical and regulatory updates on its lead program, CLN-081. CLN-081 is being evaluated in an ongoing Phase 1/2a clinical trial in non-small cell lung cancer NSCLC patients whose tumors harbor epidermal growth factor receptor EGFR exon 20 insertion mutations that have progressed on or after prior therapy in the ongoing Phase 1/2a study, CLN-081 was administered orally at dose levels including 30, 45, 65, 100 and 150 mg twice daily . The most recent data now include 39 patients treated at 100 mg BID following the addition of 3 patients who were reassigned to receive the 100 mg BID dose after enrollment at 150 mg BID was discontinued...Of 39 response evaluable patients, 16 achieved a confirmed partial response for a 41% confirmed response rate. No patients have experienced Grade 3 or greater treatment-related diarrhea or "Today's update reflects the substantial progress we have made on the CLN-081 program," said Nadim Ahmed, Chief Executive Officer of Cullinan Oncology. "CLN-081 continues to show a differentiated clinical profile relative to EGFR exon 20 agents, including a high response rate, promising response durability, and favorable safety and tolerability, which provides a potential opportunity to improve the standard of care for patients with EGFR exon 20 mutant NSCLC. The Breakthrough Therapy Designation status for CLN-081 underscores its clinical profile and has facilitated productive engagement with the FDA. As a result, we look forward to expeditiously advancing the regulatory path for CLN-081 through rapid completion of the PK food effect study and initiation of a pivotal study in the second half of 2022."

16:06 EDT Aviat Networks selected by Quickline Communications for rural broadband - Aviat Networks announced that Quickline Communications, one of the largest wireless Internet service providers in the UK, has selected Aviat Multi-Band radios to deliver highly reliable 10 Gbps capacity over extended distances to expand its business. Subscriber growth had reached the point where Quickline's existing licensed microwave links made it difficult to support new business and residential customers at the speeds they want and reliability they need.

16:01 EDT NeoGenomics trading halted, news pending

15:05 EDT Cirrus Logic announces Denise Grode as chief human resources officer - Cirrus Logic (CRUS) announced that Denise Grode has joined its executive team as chief human resources officer. In this role, she will be responsible for the company's global human resources and communications teams. Denise joins Cirrus Logic from Centene (CNC) where she served as the regional vice president, global talent management, employee experience and Centene University.

14:03 EDT WWE announces partnership to air premium events at Dave & Buster's locations - WWE (WWE) announced a new partnership with Joe Hand Promotions that will bring all of WWE's Premium Live Events to Dave & Buster's (PLAY) locations nationwide, beginning with WrestleMania this Saturday, April 2 and Sunday, April 3. "Dave & Buster's is a staple of fun and entertainment in the United States and that matches the energy of WWE Premium Live Events such as WrestleMania. We are excited about this year-round partnership and meeting new and existing fans at a place they truly enjoy," said Emilio Revelo, WWE Vice President. "With this partnership, we're incredibly excited to tune [our] screens to WrestleMania 38, as well as all the other great WWE shows and events. We look forward to welcoming WWE fans into their new clubhouse, where they can gather with other likeminded fans, enjoy great food and drinks, and never miss a minute of the action on screen," added Kevin Bachus, Sr. Vice President of Entertainment and Games Strategy, Dave & Busters.

13:53 EDT Tesla's head of AI Andrej Karpathy taking sabbatical - Andrej Karpathy, Tesla's head of AI, said via Twitter: "Taking some time off to rest&travel after almost 5 years at Tesla. Esp excited to get focused time to re-sharpen my technical edge and train some neural nets! Though I already miss all the robots and GPU/Dojo clusters and looking forward to having them at my fingertips again." Reference Link

13:14 EDT NTT Data acquires Vectorform, terms not disclosed - NTT DATA announced it has acquired Vectorform, a digital transformation and innovation company based in Detroit. The company said, "Vectorform further builds NTT DATA's commitment to expanding its global digital engineering and design capabilities and helping to accelerate clients' current and future digital transformation programs...Vectorform adds to NTT DATA's successful 2021 acquisition of Nexient by strengthening its digital application development and modernization capabilities adding innovation and design, customer experience and product development services." Vectorform's 80 team members will join NTT DATA's consulting and digital transformation business.

13:04 EDT Mino-Lok trial timetable pushed out as study was 'COVID-tized,' Mazur says

13:04 EDT Mazur says Citius still expects I/ONTAK topline data in first half of 2022

12:55 EDT Take-Two's Rockstar announces GTA+ membership program for PS5, Xbox Series - On Friday, Take-Two's (TTWO) Rockstar Games introduced GTA+ for its video game "Grand Theft Auto Online," a new player membership delivering exclusive benefits and more launching March 29. Rockstar said the membership program will work exclusively for "GTA Online" on PlayStation 5 (SONY) and Xbox Series X/S (MSFT). "Being a GTA+ Member gets you a recurring monthly GTA$500,000 direct deposit to your Maze Bank account, plus the opportunity to claim properties in and around Los Santos that unlock gameplay updates you may have missed out on, special vehicle upgrades, Member-only discounts, GTA$ and RP bonuses, and more each month," the developer said. Reference Link

12:20 EDT Pinterest announces expansions to the Creator Fund - In a company blog post, Pinterest's (PINS) creator inclusion lead Zeny Shifferaw said, "Creating a more inclusive space online means increasing our investment to support the work of underrepresented creators. Starting today, we're announcing an expanded Creator Fund program, with more opportunities for creators to participate and get hands-on support...New for 2022, we'll announce a new Fund cycle every quarter, giving even more creators access to financial resources and training. Each cycle will focus on a different content area, for more personalized training and community building. This first 2022 cycle is focused on Fashion and Beauty, inviting Fashion and Beauty creators in the US to apply. Future cycles will include topics like Food, Lifestyle and Wellness. The new format means that participants will get a mix of Pinterest training and deep industry insights from experts in the field. And we have some really exciting news: This next cohort is being sponsored by L'Oreal USA (LRLCY). Creators in the Fund will hear directly from L'Oreal USA about potential partnerships, and will also receive complimentary beauty products for creators to use within their content if they choose...Participation in the Creator Funds opens up potential brand partnership opportunities for you, and gives you access to creator-focused conferences. And because a financial leg up matters, you'll receive $25,000 in the form of a cash grant, ad credits and an equipment stipend. You'll also get a first look at new Pinterest products...The fund is based in the US for now. But we're excited to expand the program to include underrepresented creators in Brazil and the UK later this year. It's happening! Be sure to check back for updates and new opportunities over the coming months." Reference Link

12:04 EDT GM forms new unit named Commercial Growth Strategies and Operations - General Motors announced the creation of a new organization - Commercial Growth Strategies and Operations - under the leadership of Steve Hill. "This new organization will oversee current cross-brand activities that strengthen GM's brands and the company's position in the market. In addition, the group will help with the assessment and commercialization of future business opportunities that support GM's revenue growth commitments," the company said in a statement. Hill has served as vice president of Chevrolet since November 2019. Scott Bell, currently president and managing director of GM Canada, will repatriate to the U.S. and lead the Chevrolet brand, as vice president of Global Chevrolet. Marissa West, currently GM executive chief engineer, Global Mid-Size Truck, Medium Duty Truck and Van, is appointed president and managing director of GM Canada. The new executive leadership appointments take effect April 1. Reference Link

12:00 EDT Benson Hill falls -15.9% - Benson Hill is down -15.9%, or -80c to $4.20.

12:00 EDT Terran Orbital falls -28.4% - Terran Orbital is down -28.4%, or -$3.61 to $9.08.

12:00 EDT AMC Entertainment rises 25.9% - AMC Entertainment is up 25.9%, or $5.24 to $25.48.

11:58 EDT Telix granted orphan status for stem cell conditioning treatment - The FDA granted Telix Pharmaceuticals orphan status for its conditioning treatment prior to hematopoietic stem cell transplant. Reference Link

11:09 EDT JetBlue to add 5,000 jobs in New York City in 2022 - JetBlue and New York City Mayor Eric Adams announced that the company will be adding 5,000 jobs in New York City in 2022. JetBlue will also work with the city to create a new workforce partnership to connect more New Yorkers with high JetBlue jobs and to develop a strong pipeline for future careers at the airline. Mayor Adams joined JetBlue leaders at a major hiring event to assist in filling many of these new positions. The hiring event, held at JetBlue's hangar at John F. Kennedy International Airport, facilitated on the spot interviews and conditional hiring of diverse candidates for a variety of positions within the JetBlue operation based in New York City, including roles in airport operations, ground operations, technical operations, inflight, information technology and other support center roles. To encourage even more travel to New York City, JetBlue Vacations is launching a travel promotion to remind customers that the city is ready and waiting for them. JetBlue Vacations is offering $200 off vacation packages for those heading to New York City.

10:33 EDT Teck Resources, UBC Applied Science partner to reduce bacteria - UBC and Teck Resources announced progress on programs being funded through Teck's Copper & Health program including the installation of over 400 antimicrobial patches on high-touch surfaces at the University of British Columbia Faculty of Applied Science and research that will further the development of advanced copper coating technology to reduce the spread of infection. Health Canada-registered copper patches have been installed in public areas on surfaces including door handles and railings in nine UBC Applied Science buildings. Manufactured by the Canadian company Coptek Copper Covers, the patches are self-sanitizing adhesive copper covers that are registered with Health Canada and the U.S. Environmental Protection Agency, proven to continuously kill 99.9% of bacteria on surfaces within two hours of contact. Antimicrobial copper patches will create a safer work and learning environment for students, faculty and staff due to copper's natural antimicrobial properties. The installations were completed in two phases with 80 patches installed during the first phase in November 2021 followed by 365 in February 2022. In addition, Teck's Copper and Health program also provided funding to Dr. Amanda Clifford, an Assistant Professor from UBC's Department of Materials Engineering for research to develop advanced copper coating technology. The new coating is expected to outperform pure copper in terms of reducing the spread of aggressive infections contracted through contaminated surfaces in hospitals and other health care settings. The research results will go through a peer review process and are expected to be released this year.

10:19 EDT Amylyx sinks after FDA posts briefing docs for lateral sclerosis therapy - In briefing documents ahead of the March 30 advisory committee, the FDA said that although Amylyx Pharmaceuticals claims the CENTAUR study met its prespecified primary endpoint, the study "demonstrated only a modest p-value using non-preferred analysis methods that ignore the loss of data due to patient deaths during the study and relied on a questionable linearity assumption of the ALSFRS-R over time." The FDA added, "There was also a moderate proportion of missing data and a randomization implementation problem such that the first 18 patients in a row received the drug, which reduce the persuasiveness of the study." This briefing document presents results from the AMX0035 amyotrophic lateral sclerosis development program. Shares of Amylyx are down 15% to $21.15 in early trading.

10:15 EDT Amylyx drops 15% to $21.15 after FDA posts briefing docs for panel

10:10 EDT AMLX ETF trading resumes

10:00 EDT Murphy Oil falls -11.6% - Murphy Oil is down -11.6%, or -$5.00 to $38.15.

10:00 EDT Valens Semiconductor falls -15.9% - Valens Semiconductor is down -15.9%, or -$1.10 to $5.83.

10:00 EDT SIGNA Sports United rises 19.6% - SIGNA Sports United is up 19.6%, or $1.40 to $8.50.

09:51 EDT BOS Better Online Solutions announces $2.4M order for delivery in 2022 - BOS Better Online Solutions announced that its Supply Chain Division has received an order in the amount of $2.4M for delivery this year. Hagit Eliyahu, VP of Sales of the Supply Chain Division, stated: "This is an order from an existing customer in Israel, and it demonstrates the strong added value of our supply chain services to manufacturers."

09:47 EDT Barnes & Noble Education falls -10.3% - Barnes & Noble Education is down -10.3%, or -42c to $3.66.

09:47 EDT Dingdong rises 8.9% - Dingdong is up 8.9%, or 31c to $3.78.

09:47 EDT Poly rises 48.6% - Poly is up 48.6%, or $12.74 to $38.94.

09:30 EDT 22nd Century VLN cigarettes obtain Illinois tobacco product listing - 22nd Century Group announced that it has received notification from the Office of the Illinois Attorney General's Tobacco Enforcement Bureau that its VLN cigarettes will be listed in the Illinois Directory of Participating Manufacturers effective April 4, 2022. Registration permits the Company to begin distributing VLN as part of its Chicagoland pilot program. Illinois is the second most expensive cigarette retail market in the United States. The Centers for Disease Control and Prevention estimated that 15.5% of Illinois adults aged 18 years or older smoke cigarettes, higher than the national average of 12.5%, according to 2020 statistics. After 20 years in development and 10 years in clinical trials, VLN received the FDA's first MRTP authorization granted for a combustible tobacco cigarette. 22nd Century is pursuing registration in all 50 states as it readies for national launch following its Chicagoland pilot program.

09:22 EDT AIG teams with BlackRock to manage certain life & retirement assets - American International Group (AIG) and BlackRock( BLK) announced significant partnerships where certain liquid fixed income and private placement assets will be managed by BlackRock. The arrangements contemplate BlackRock managing up to $60B of the global AIG investment portfolio and up to $90B of the Life & Retirement investment portfolio. Additionally, BlackRock's Aladdin platform will provide investment management technology for both AIG and Life & Retirement.

09:16 EDT Datasea, Guangdong Canbo enter three-year collaboration agreement - Datasea announced that its subsidiary company named Shuhai Shengxiao Technology has entered into a three-year collaboration agreement with Guangdong Canbo Electrical. The collaboration will support the advancement of next-generation disinfection cabinet with the integration of Shuhai Shengxiao's innovative acoustic intelligence-enabled sterilization technology. The new collaboration will focus on leveraging the respective strengths of Shuhai Shengxiao and Canbo to promote product evolution and enhance user experience. Shuhai Shengxiao will provide technology called "high-frequency sound air coupling microorganisms and synergistic disinfection" to upgrade Canbo's disinfection cabinet products and tackle the main problems of current disinfection cabinet products such as heat generation and ozone odor, and effectively bring the disinfection time from 3mins down to 10 seconds. Under the agreement terms, both companies will work closely and take on responsibilities for subsequent development and commercialization activities. Once the technology integration and product development are finished and quality assurance is confirmed, the product's sales are expected to reach 500,000 units annually.

09:12 EDT WISeKey renews, expands smart card reader agreement with Identiv - WISeKey International Holding (WKEY) announced that it is renewing and expanding its business in smart card readers with Identiv (INVE). In 2022, WISeKey will be supplying Identiv with high-end smart card reader chips for over $1M value. The partnership extends to Identiv's contact, contactless, and dual-interface smart card readers, targeting applications in healthcare, pharmaceuticals, government, and education. Public and private organizations use Identiv's identity verification devices when seeking the highest security and performance in access management.

09:08 EDT Arcimoto 'applauds' Christofferson-Harper autocycle bill in Utah - Arcimoto announced that drivers of Arcimoto Fun Utility Vehicles in Utah will no longer need to have a motorcycle endorsement under legislation signed by Governor Spencer Cox. The bill, HB391, sponsored by Representative Kay Christofferson and Senator Wayne Harper, brings Utah in line with other states that do not require a motorcycle license to operate an autocycle such as those built by Arcimoto. "We've had some epic rides through the National Parks of Utah, and it is truly one of the most spectacular states in the nation to explore from the cockpit of an Arcimoto vehicle," said Mark Frohnmayer, CEO and Founder of Arcimoto. "We applaud Governor Cox, Representative Christofferson, and Senator Harper for passing this forward-thinking legislation which will give the citizens of Utah access to new clean transportation vehicles that are made right here in the U.S."

09:06 EDT Rogers Communications launches 5G standalone network in Canada - Rogers Communications launched the first commercial 5G standalone network in Canada and one of the first globally, turning on the next-generation service after completing the rollout of Canada's first national standalone 5G core and the country's first 5G standalone device certification. Rogers 5G SA Core network has been built from the ground up based on the latest cloud native technologies, enabling more advanced wireless capabilities like ultra-low latency, network slicing and mobile edge computing and expanding Rogers 5G footprint. Rogers 5G SA is built to scale massively and will support the unprecedented growth of IoT devices in the years to come. 5G Core and 5G RAN slicing enables Rogers to deliver innovative new services to customers such as dedicated private networks, public safety applications and access to edge compute for AR/VR consumer applications.

09:04 EDT CME Group announces launch of Micro Bitcoin and Micro Ether futures - CME Group launched options on Micro Bitcoin and Micro Ether futures, further expanding its suite of cryptocurrency derivatives offerings. "The launch of these micro-sized options builds on the significant growth and liquidity we have seen in our Micro Bitcoin and Micro Ether futures," said Tim McCourt, CME Group Global Head of Equity and FX Products. "Sized at one-tenth of their respective underlying tokens in size, these contracts will offer a wide range of market participants - from institutions to sophisticated, active, individual traders - greater flexibility and precision to manage their exposure to the top two cryptocurrencies by market capitalization."

09:03 EDT UPS, ESW enter integrated international e-commerce and shipping agreement - ESW announced an agreement with UPS that will provide integrated international e-commerce and shipping capabilities for brands aiming to accelerate their direct-to-consumer, or DTC, expansion, enabling them to be more effective at reaching global consumers via cross-border ecommerce. Through this new bundled offering, UPS customers and ESW clients will see significant capabilities to localize their online shopping experience and leverage UPS's global transportation and customs brokerage platform for delivery.

09:01 EDT Capital One becomes official partner of Major League Baseball - Capital One announced it is a new official partner of Major League Baseball as the league's Official Bank and Credit Card Partner, as well as the presenting sponsor of the World Series, North America's most historic team sports championship. This multi-year sponsorship agreement will bring Capital One cardholders access to one-of-a-kind opportunities and exclusive events and benefits. Additionally through this sponsorship, Capital One is now an Official Partner of Minor League Baseball and Little League Baseball and Softball. Starting on Tuesday, March 29th, Capital One rewards cardholders will be able to redeem their rewards for tickets to MLB games for all 30 teams through the recently announced Capital One Entertainment ticketing platform. Throughout the season, these cardholders will have the opportunity to access MLB tickets, from Opening Day through the Postseason, including the World Series presented by Capital One, as well as one-of-a-kind VIP experiences, such as private on-field sessions with MLB legends, batting practice access and more.

08:54 EDT Itron, Fuengirola to partner on smart city - Itron and the City of Fuengirola, Spain are joining forces to transform the municipality into a smart city. Home to more than 82,000 permanent residents and more than triple that during the summer months, the City of Fuengirola will deploy Itron's smart city platform, which includes a city-wide mesh network optimized for industrial IoT devices and Itron's device and data management platform, SLV. Deployment of the solution is expected to be completed by the end of 2022

08:53 EDT Wuhan General: Medspresso, Liviana carried by 100 South African retailers - WUHAN GENERAL GROUP is pleased to share the following update: Medspresso and Liviana are delighted to announce that their Premium Coffee and Extra Virgin Olive Oil ranges are now listed in 100+ independent brick and mortar stores in the greater Cape Town, South Africa region. Since the launch of Medspresso and Liviana late-2021, the brands have grown significantly in the Western Cape, with the number of stockists increasing weekly. There has also been momentous growth on social media as the stockists share and promote the products on their platforms and websites.

08:50 EDT Alpine 4 Holdings' ElecJet releases results from BIC on AX batteries - Alpine 4 Holdings announced that its subsidiary, ElecJet, has released specifications on third-party testing of its AX Class of Solid-State Batteries with current production capabilities of 100,000 units per month. ElecJet, earlier this month, engaged the Battery Innovation Center in Newberry, Indiana to have a third-party verification of the specifications of its AX Class of Solid-State Batteries that ElecJet has already confirmed in its laboratory. ElecJet has engaged the BIC to verify the results of the G-AX Class as well, later in 2022. The AX Battery Class is a Ceramic Oxide solid-state battery and comes in the form of a 31Ah Solid-State Battery and a 10Ah Solid-State Battery. All of the AX and G-AX Classes are true solid-state batteries and are not semi solid-state batteries. ElecJet engaged the BIC to perform several types of testing from verification of its charge capabilities to energy density / power density, to induced failure point testing. The BIC tested two versions of the AX 31Ah. These two subclasses are designed for different market segments. The AX-01 is an ultra-safe version that can withstand a variety of survivability use cases. The AX-01 has a slightly different material composition that enables its amazing survivability characteristics. The BIC confirmed that the AX-01 withstood being punctured, then folded, and finally crumpled while still holding a charge. The cell was then put through a temperature destruction test where the cell survived to a temperature of 410 degrees Fahrenheit. Details of the tests are described below: Nail Puncture Test: The AX-01 was punctured by a 3mm diameter nail. The nail was left inside the battery, purposely causing the battery to short, of which it did for over an hour while being suspended in the air. The battery's temperature fluctuated but would hover at around 98.6 degrees F near the end of the hour with a maximum measured temperature of 101.76 degrees F. After, the battery was lowered back on to the metal surface for the nail to be removed and the battery quickly returned to room temperature. One amazing feature of the battery was that during the entirety of the test, the AX-01 was holding voltage and remained functional. Fold/Crumple Test: After the puncture test, the AX-01 was folded over its long sideby a mechanical actuator. After it was folded to the point that both ends were touching each other, the battery was attempted to be folded over again by its short side. After being folded with as much force as the mechanical actuator could press out, the battery remained functional throughout the entire process and remained at room temperature. Note: Standard lithium batteries would normally catch on fire after being folded at even a small angle. Thermal Heat Test: The battery was placed in an oven and the oven would slowly and constantly increase in temperature to test the battery's heat exposure breaking point. The temperature of the battery was brought up to 428 degrees F before thermal runaway occurred creating a new BIC record. Once the battery eventually caught fire, the fire was unlike other thermal runaways where a battery spews a stream of fire from a concentrated point, but rather was much more contained to the surface area across the battery. Note: Typical lithium batteries would have a thermal runaway at 266 degrees F and the previous highest recorded temperature before thermal runaway on cells of similar capacity, with fielded chemistries, at the BIC was 302 degrees F. The BIC confirmed that the AX-01 measured a discharge energy of 111.41Wh at a C/2 rate. At a nominal volume of 0.17571 Liters for each cell and a nominal mass of 0.395 kg, this translates to 634Wh/L and 282Wh/kg of energy densities which are both dramatic improvements over current battery technology. The AX-02 is an energy dense cell that also has a high degree of survivability but trades some of the safety material features of the AX-01 for much higher power densities and higher life cycles. The BIC confirmed that the AX-02 has the capability to charge at 4C. This means that the battery can fully charge in just 15 minutes. The AX-02 is also capable of 7C discharging and over 2,400 life cycles, both of which are currently in the process of being confirmed by the BIC. The BIC also confirmed that the AX-02 measured a discharge energy of 113.213Wh at a C/2 rate. At a nominal volume of 0.17571 Liters for each cell and a nominal mass of 0.395 kg, this translates to 644Wh/L and 287Wh/kg of energy densities which are both dramatic improvements over current battery technology.

08:47 EDT Dermata Therapeutics announces upcoming milestones - DMT310 Phase 2 trial in mild-to-moderate psoriasis. Based on the clinical results seen in its Phase 1b trial, the Company plans on initiating a DMT310 Phase 2 study in mild-to-moderate psoriasis in the first half of 2022, with topline results expected in the first half of 2023. The trial will be double-blinded, randomized, placebo-controlled which is anticipated to enroll approximately 150 mild-to-moderate psoriasis patients at clinical sites in the United States. DMT310 Phase 3 trials in moderate-to-severe acne. After the End of Phase 2 meeting with FDA planned for the first quarter of 2023, the Company plans to initiate the two Phase 3 trials in the first half of 2023. Results from these two trials are expected in the second half of 2024, with an intended filing of the NDA approximately 6 months after completion of the trials.

08:44 EDT Infinitum urges Katapult board to commence full strategic review - Infinitum Partners, a significant stockholder of Katapult Holdings, with an ownership interest of approximately 1.3% of the Company's outstanding shares, today announced that it has delivered an open letter to the Katapult board of directors. The letter read in part, " Since going public through a merger with FinServ Acquisition Corp. in June 2021 at an almost $1 billion valuation, roughly 80% of Katapult's equity value has been destroyed under its current management and board of directors. Katapult's dismal performance of late starkly contrasts with its previous track record as a private company, when its growth was outstanding by any metric. In our opinion, this is partially explained by wildly unrealistic projections that were made while the SPAC deal was marketed, resulting in the Company subsequently missing every single target set then - by embarrassing margins. We also believe that this has been compounded by inaction and ineptitude by the Company's management and the Board. At this point, based on our own research, in-depth discussions with other investors, and prevailing market conditions, it is clear to us that in order to protect what is left of shareholder value, Katapult must urgently explore strategic options that would take the Company private. Specifically, we encourage the Board to focus on potential acquisitions by strategic buyers and banking institutions. In our view, the past year has proved beyond reasonable doubt that Katapult was never, and is still not, ready to be a public company. We know there would be interest from a strategic buyer based on discussions we had and similar transactions that have occurred in the marketplace...Amidst the dramatic deterioration during 2021, the Board seems to have remained out of touch. It has authorized an incremental $20 million SG&A expenditure and approved additional operating expenses, spending balance sheet cash without assuring shareholders that there is a real plan for how such investments will yield recovery, growth, and a return on their investment. In our view, this highly irresponsible move further threatens shareholder value unless the Company imminently signs a large enterprise merchant partner. Katapult was a fantastic grower and compounder in nearly every category as a private company. Between 2018 and 2020, revenues grew at a significant pace and company had $40mm of EBITDA in 2020. Since going public, however, the Company has flailed and floundered, missing expectations, failing to deliver on grand promises, and refusing to adapt to an increasingly bleak situation. In addition, the company as a public company had higher revenues in 2021 but SG&A went up dramatically and profitability declined. Our view is that the Company is fundamentally headed in the wrong direction. In hindsight, Katapult was not ready to be a public company at the time of the SPAC transaction, and would still be better off as a private company today and for the foreseeable future. Therefore, we urge the Board to immediately engage with financial and legal advisors to commence a full strategic review. Based on current market comps, we believe that the Company could be worth $8-10 per share to a strategic buyer or a banking institution. We have repeatedly voiced our views privately in discussions with Katapult's management and members of the Board. However, at this point we find ourselves with little choice but to publicly air our grave misgivings about the state of affairs at the Company, and hope that this will encourage the Company to finally take decisive action. While we remain open to further conversations with the Company, we reserve all options available to us to protect the rights and shareholder value of all investors in Katapult."

08:40 EDT Fluidigm urges stockholders to vote for proposals at special meeting - Fluidigm Corporation announced that it has entered into an agreement with Casdin Capital and Viking Global Investors LP modifying the provision of the proposed strategic capital infusion transaction that permitted Fluidigm to adjourn the Special Meeting of Stockholders to April 1, 2022, instead of the allowed aggregate of 20 business days. Importantly, the parties will terminate the purchase agreements if Fluidigm stockholders do not approve the matters presented at the Special Meeting. The company said, "Fluidigm's Board of Directors approved these modifications for a number of reasons, including the following: Only Financing Solution Available; Non-Negotiable. The only actionable financing solution available to Fluidigm is the one presented by Casdin and Viking, who have made it clear through repeated communications that they will not modify the terms and conditions of their proposed investment. Urgent Need for Capital. Fluidigm has an urgent need to resolve its capital and liquidity issues as evidenced by the going concern uncertainty included in Fluidigm's 2021 financial statements. Adverse Effect on All Stakeholders. The adverse impact of continued financial uncertainty on our relationships with customers and suppliers, as well as material retention risks for employees, will significantly negatively affect Fluidigm's operating results, enterprise value and investor confidence in Fluidigm. The Board believes that the proposed financing transaction is the only currently actionable alternative available to stockholders and is in the best interests of Fluidigm, its stockholders, and other stakeholders, including its employees, customers, and other partners. While the market is clearly supportive of the strategic capital infusion - as evidenced by the stock price outperformance of Fluidigm stock versus overall peers - a very small number of shares are still needed to approve the transaction. The Board reminds all stockholders that even if an alternative solution were available, Fluidigm is unable to engage with any third party as long as its agreements with Casdin and Viking remain in force. The Board unanimously recommends that stockholders vote "FOR" all Proposals at the Special Meeting. Your vote is very important regardless of the number of shares of Common Stock that you own."

08:36 EDT Capricor Therapeutics reports results from Phase 2 INSPIRE study - Capricor Therapeutics announced that its Phase 2, INSPIRE study evaluating a single-dose intravenous infusion of CAP-1002 as a potential treatment option for hospitalized patients with advanced symptoms of COVID-19 met its primary objective of safety. All efficacy endpoints were exploratory as the study was not powered to detect treatment differences. In the study of 63 randomized patients, 31% were admitted to the ICU prior to initiation of treatment. The WHO ordinal scale indicated severe disease in 82% of patients. Study Findings: Safety: The results from the INSPIRE trial suggest that CAP-1002 was safe, well tolerated and consistent with the historically observed safety profile of this therapy. Exploratory Efficacy: Overall mortality in the study was 20%, with 6 deaths in the placebo group and 5 deaths in the CAP-1002 group. "We were pleased that CAP-1002 was shown to be safe and well-tolerated in this group of patients that were profoundly ill with symptoms of COVID-19 which bodes well for the general safety and tolerability of infused CAP-1002 even in this heterogeneous and severely sick population of patients," said Linda Marban, Ph.D., Chief Executive Officer of Capricor. "In light of the effectiveness and widespread use of available vaccines, the reduction in mortality and the decline in COVID-19 hospitalization rates in the United States, we will continue to evaluate the next steps for this program. Further, as we continue to analyze this dataset in more detail, we will remain open to discussing potential partnering opportunities should they become available."

08:35 EDT Citizens Financial announces overdraft-free checking account - Citizens announced a new, overdraft-free checking account. Citizens EverValue Checking offers protection from overdraft so that consumers don't have to worry about overspending their account.

08:35 EDT Prothena announces FDA clearance of IND for PRX012 - Prothena announced that the U.S. Food and Drug Administration, FDA, has cleared the investigational new drug, IND, application for PRX012, a potential best-in-class anti-amyloid beta antibody in development for the treatment of Alzheimer's disease, AD. Prothena has initiated the Phase 1 single ascending dose, SAD, study to investigate the safety, tolerability, immunogenicity and pharmacokinetics of PRX012 in both healthy volunteers and patients with AD. Prothena expects to initiate the Phase 1 multiple ascending dose study by year-end 2022. PRX012 is a next-generation, high binding potency antibody, designed to enable subcutaneous dosing on a convenient administration schedule. "With Alzheimer's affecting more than 50 million people worldwide, we are committed to bringing a paradigm-shifting treatment to patients as quickly as possible. Having submitted our IND during this first quarter, we are excited to announce the initiation of this first-in-human study. PRX012's high binding potency and subcutaneous administration has the potential to serve as a foundational anti-Abeta treatment for Alzheimer's disease," said Gene Kinney, Ph. D., President and Chief Executive Officer. "We intend to leverage our multiple decades of experience and expertise in protein dysregulation together with clinical and regulatory learnings from first generation anti-Abeta therapies to maximize the probability of success for our PRX012 program to deliver a best-in-class treatment to patients with Alzheimer's and their families."

08:34 EDT WWE, Fanatics announces long-term sports and entertainment partnership - WWE and Fanatics announced a long-term sports and entertainment partnership that will see Fanatics utilize its expanded digital sports platform to create a new, enhanced experience for WWE fans globally across several businesses, including e-commerce and licensed merchandise, as well as physical, digital, and non-fungible token, or NFT, trading cards. Through the deal, WWE will benefit from many capabilities across the Fanatics platform to create more opportunities for its global fanbase to showcase their pride and passion for WWE, its marquee events, and star-studded roster. The businesses that will work together to create an elevated fan experience include Fanatics Commerce, Fanatics Collectibles and Candy Digital. As part of the agreement, this summer Fanatics will exclusively re-introduce a new, rapid e-commerce and mobile destination, WWE Shop, giving fans around the world access to a leading assortment of WWE merchandise across all categories, including apparel, hard goods, such as title belts, headwear, accessories and more. Fanatics will work closely and collaboratively with the talented teams at WWE who have significantly grown this business in-house for decades, and the company will also add rights to design, manufacture and distribute real-time, on-demand merchandise collections to celebrate unpredictable WWE moments and new and emerging Superstars.

08:31 EDT WiMi Hologram Cloud's WiMi HoloVR approved by FCC for U.S. market - WiMi Hologram Cloud announced that its Virtual reality head-mounted display product for the consumer market, "WIMI HoloVR" has been approved by the Federal Communications Commission to enter the U.S. market.

08:29 EDT Cerberus Cyber elects Devoto to board of directors - Cerberus Cyber Sentinel (CISO) announces that Ashley Devoto has been elected to its board of directors. Devoto is the chief information security officer, CISO, for Cerberus Sentinel, where she is responsible for guiding the company's global cybersecurity strategy and leading all cybersecurity operations. Concurrently, Sandra Morgan moves to Cerberus Sentinel's Advisory Board from the board of directors. Prior to joining the company this month, Devoto served as CISO for Booz Allen Hamilton (BAH).

08:27 EDT Bigg Digital Assets' Netcoins launches new digital assets - BIGG Digital Assets' Netcoins is pleased to announce the launch of 5 new coins on the platform: SHIB, DOGE, MATIC, FTM and MANA. On March 24th, Netcoins received approval for an update to its restricted dealer license, which was requested in late 2021, enabling a broader offering of coins on the platform. These 5 coins represent the first rollout of our upcoming coin additions, with multiple rollouts expected to follow. Netcoins would also like to provide an update on US expansion. The company has made the strategic decision to push the US launch beyond Q1 2022 for three reasons. First, Netcoins wants to deploy a wider range of coins on the platform, prior to launch, in order to offer a highly competitive product in the US market. Second, the team has found a number of US focused service providers, which will be implemented in order to offer a superior KYC and customer experience to US customers. Finally, the regulatory landscape in the US continues to evolve with the recent Biden executive order, and our legal team is ensuring we are set for a smooth launch. Despite the postponement, we continue to push towards a successful launch in the US in 2022 as soon as possible. Netcoins has secured US banking, adopted a US compliance program, established its US MSB license and provided "No-Action Letters" to Texas and California indicating our intention to launch a crypto trading platform in their jurisdictions.

08:24 EDT DatChat to launche metaverse advertising, NFT monetization platform - DatChat announced it will launch the VenVuu metaverse advertising and NFT monetization platform. DatChat also opened pre-sale registration for its new VenVuu Dynamic Content NFT on the VenVuu.io website. VenVuu is an advertising platform that allows metaverse landowners and brands to connect using DatChat's proprietary patented and patent pending technology. "We believe this to be a landmark moment for the Metaverse, as it is the first simple solution allowing users to monetize their metaverse parcels while enabling brands a broad reach in the metaverse," said DatChat CEO Darin Myman. "Each VenVuu Dynamic NFT is a unique NFT like owning your own multi-media outlet that you own and control in 'Your World'. Not only will this create unique opportunities for supporters of DatChat, but will also be a significant contributor to our Company's ability to grow our top-line."

08:20 EDT Analog Devices, Gridspertise team on smart grid resiliency, electrification - Analog Devices, and Gridspertise, the new subsidiary of the Enel Group providing cutting-edge sustainable solutions to distribution system operators DSOs, announced a collaboration to advance the resiliency and quality of smart grids around the world. The collaboration enables the development of new hardware and software that support distribution grid self-healing and adaptation in response to the significant changes in energy supply and demand as renewable energy sources are brought online.

08:18 EDT TriCo Bancshares completes merger with Valley Republic Bancorp as of March 25 - TriCo Bancshares has completed its previously-announced merger with Valley Republic Bancorp as of March 25 The combined company, operating as TriCo Bancshares with its banking subsidiary, Tri Counties Bank, anticipates having total assets of approximately $10.1B as the result of the merger. "We are excited to combine two community-focused financial institutions which are both significantly involved in the markets they serve," said Richard P. Smith, President and CEO of TriCo and Tri Counties Bank. "We look forward to providing our new clients with additional lending capabilities and expanded product offerings while delivering our unique brand of Service With Solutions. With the completion of the merger, TriCo has appointed Anthony L. Leggio to its board of directors. Mr. Leggio served as a director of Valley and Valley Republic Bank since incorporation in 2016 and 2008, respectively. Mr. Leggio has been President/Manager of Bolthouse Properties, LLC, Bakersfield, CA, a diversified real estate development company with commercial, residential and agricultural holdings since 2006. He is a director of Tejon Ranch Company ( TRC), Lebec, CA, a growth-oriented, fully diversified real estate development and agribusiness company since 2012. Pursuant to the terms of the Agreement and Plan of Merger dated as of July 27 , between TriCo and Valley, each share of Valley common stock has been converted into the right to receive 0.95 shares of TriCo common stock, with cash to be paid in lieu of fractional shares. TriCo issued approximately 4.1M shares of common stock in the merger. As a result, former Valley shareholders will own approximately 12% of TriCo's outstanding common stock immediately following the merger.

08:15 EDT Enservco reduces debt, strengthens balance sheet - Enservco Corporation announced it has retired its $13.8 million senior revolving credit facility with East West Bank for total consideration of approximately $9.4 million, which includes an initial payment of $8.4 million in cash and future payments of up to $1.0 million from a limited portion of net proceeds from receivables financing. As a result of the refinancing, Enservco's debt was substantially reduced and predominantly reclassified as long-term liabilities with four- to six-year terms. Equally important, the refinancing will have minimal impact on aggregate monthly debt and lease obligations, thus substantially improving and stabilizing the Company's capitalization. The refinancing included: A $6.225 million master equipment lease; A receivables factoring line of up to $10 million; A $1.2 million convertible subordinated note Specifically, the Company's Heat Wave Hot Oil Service unit entered into a Master Lease Agreement with Utica Leaseco, LLC, whereby Utica provided a $6,225,000 master equipment lease collateralized by Enservco equipment. The lease has a 51-month term at an effective rate in the range of 13.50% to 15.46% based on performance metrics. After 12 months, the Company has the option to prepay $1.0 million of the obligation. Heat Waves further entered into an Invoice Purchase Agreement with LSQ, which will provide receivables factoring to the Company for a term of 18 months. The agreement calls for LSQ to advance up to 85% on up to $10 million of accounts receivable factored by Heat Waves at an effective annual interest rate of approximately 7.3%. LSQ provided for $2.4 million in immediate financing at the close of the refinance under the accounts receivable factoring facility, of which $1.2 million was used in the initial payment to East West Bank, and $1.2 million was used to pay off a working capital loan provided during the first quarter of 2022 by Cross River Partners, an entity controlled by Rich Murphy, Enservco's Executive Chairman. The third component of the refinancing includes the issuance by the Company of a $1.2 million Convertible Subordinated Note to Cross River Partners. The note has a six-year term, bears interest at 7% per annum and has interest only quarterly payments commencing June 30, 2022.

08:14 EDT RioCan REIT, Harden enter property management agreement - RioCan Real Estate Investment Trust announced that effective July 1st, 2022, Harden will assume third-party property management responsibilities for RioCan's 18 Quebec retail properties that comprise RioCan's entire Quebec portfolio, outside of Gatineau. This agreement strengthens RioCan's regional position, leveraging Harden's local expertise and full suite of property management capabilities tailored for the market, including leasing, development, construction, and administration services. RioCan and Harden have an established relationship, with each owning a 50% interest in Les Galeries Lachine in Montreal, where Harden is responsible for the management, leasing, and redevelopment of the property. Recently, RioCan agreed to sell a 50% interest in the Trust's Mega Centre Notre-Dame property to Harden for $34.5M. This transaction is expected to close in the first quarter of 2022, subject to customary closing conditions.

08:13 EDT Mullen Automotive expects to report in excess of $65M in cash, cash equivalents - Mullen Automotive announces that it expects to report in excess of $65 million in cash and cash equivalents when it files Form 10Q for the Company's second quarter ending March 31, 2022. "We've made tremendous progress in key areas over the past three months," said David Michery, CEO and chairman of Mullen Automotive. "With the financing we received, we now have more than enough capital to execute on our commitments for 2022, including the start of the Mullen FIVE EV Crossover program and continued development on the Mullen ONE EV Cargo Van program. The Company's balance sheet is the strongest it has ever been in our history."

08:12 EDT Tantech Holdings unit wins additional 10 vehicle order - Tantech Holdings announced that its subsidiary, Shangchi Automobile Co., Ltd., won an additional 10 vehicle order. The latest order for customized, high-end black and yellow midibuses is expected to be delivered to the customer in Ecuador in May.

08:11 EDT Oryzon Genomics appoints Douglas Faller as global CMO - Oryzon Genomics (ORYZF) announced the appointment of Douglas Faller, M.D., Ph.D., to the role of Global Chief Medical Officer. Dr. Faller has over 30 years of clinical hematology/oncology expertise and broad drug development experience in the design and execution of early to registrational clinical programs across oncology and rare diseases and will lead Oryzon's global clinical development strategy. Based in Boston, Dr. Faller will strengthen Oryzon's permanent presence in the US as it builds up strategic partnerships with US hospitals and research institutions to develop its pipeline and clinical programs. Dr. Faller joins Oryzon from Takeda (TAK), where he was Executive Medical Director and Global Clinical Leader for more than 5 years.

08:10 EDT In8bio presents clinical update on ongoing Phase 1 trial of INB-100 - IN8bio presented a clinical update from the ongoing Phase 1 trial of INB-100. This program is an allogeneic, or donor-derived, gamma-delta T cell therapeutic candidate in development for patients with leukemia undergoing haploidentical hematopoietic stem cell transplant, HSCT. Two of the INB-100 patients treated have been in remission for nearly two years, and the third patient is in continuing remission at nine months post-treatment. The exploratory clinical correlative data highlights the robust reconstitution of the immune system of treated patients. The data show positive trends in levels of immune cells, including alpha-beta T cells, B cells and gamma-delta T cells. This suggests that the systemic immune system may show long-term positive trends in treated patients. The toxicity profile continues to be manageable with no treatment-related Grade 3 or greater adverse events. "We are encouraged by the patients' responses to INB-100 treatment given this population's high risk for recurrence," said Lawrence Lamb, Ph.D., Chief Scientific Officer and co-founder of IN8bio. "As we near the two-year mark in remission for our first and longest enrolled patient, we continue to monitor data from our ongoing clinical correlative studies, which are indicating a positive systemic immune response following the infusion of INB-100. Patient recruitment in this trial is continuing, and we look forward to releasing further clinical and correlative data with additional patients later this year."

08:09 EDT BJ's Wholesale teams with DoorDash for 'demand grocery delivery' in 17 states - BJ's Wholesale Club (BJ) announced a partnership with DoorDash (DASH) to offer on-demand grocery delivery from 226 BJ's locations across 17 states. BJ's is the first wholesale club available on the DoorDash marketplace, providing consumers with access to home essentials and grocery needs on-demand. BJ's products can be purchased directly on the DoorDash app, offering members and non-members alike access to thousands of BJ's items on-demand. BJ's members can also link their wholesale club card to receive lower, member-only pricing... "BJ's is proud to bring the convenience and value our members know and love to even more shoppers through the DoorDash marketplace," said Monica Schwartz, executive vice president and chief digital officer, BJ's Wholesale Club. "We are excited to expand easy shopping solutions for our members, while also bringing BJ's wide assortment and exclusive products to new potential members."

08:08 EDT Heliogen, Woodside Energy announce project agreement - Heliogen and Woodside Energy, a wholly-owned subsidiary of leading Australian energy producer Woodside Petroleum, announced a project agreement for the commercial-scale demonstration deployment of Heliogen's AI-enabled concentrated solar energy technology proposed to be built in Mojave, California.

08:08 EDT PetMed Express appoints Diana Purcel to board of directors - PetMed Express announces that Diana Garvis Purcel has been appointed to the PetMed Express Board of Directors as a new independent director, effective April 4, 2022. Purcel will also serve as the next Chair of the Board's Audit Committee when she assumes that position, currently held by Ronald Korn, following Korn's retirement at the end of his current term in July 2022. Purcel has 20 years of experience as a Chief Financial Officer, including 17 years with publicly traded companies.

08:06 EDT Chipotle to relaunch Guac Mode - Chipotle Mexican Grill announced it is relaunching Guac Mode, an exclusive benefit for Chipotle Rewards members that unlocks access to surprise free guac rewards throughout the year, to celebrate the three-year anniversary of the Chipotle Rewards loyalty program. March 28 through March 31, newcomers and existing Chipotle Rewards members who are not Guac Mode verified can join Guac Mode by visiting chipotle.com/guacmodeverified. When Guac Mode is activated by Chipotle, Chipotle Rewards members will see an extra reward in the My Rewards section of their account.

08:05 EDT Charles River announces Flavia Pease as next CFO - Charles River Laboratories (CRL) International announced that it will appoint Flavia H. Pease as its next Chief Financial Officer, succeeding David R. Smith, who previously announced on January 11th that he intends to retire. Ms. Pease will join Charles River as Corporate Executive Vice President on April 25th, and is expected to assume the role of Chief Financial Officer after the filing of the Company's Quarterly Report on Form 10-Q in early May 2022. Ms. Pease will join Charles River after more than 20 years in financial leadership roles at Johnson & Johnson (JNJ ), most recently serving as Vice President and Group Chief Financial Officer of Johnson & Johnson's global Medical Devices business. As Corporate Executive Vice President and Chief Financial Officer at Charles River, Ms. Pease will lead the Company's global Finance organization and will be responsible for overseeing the Accounting, Tax, Treasury, Investor Relations, Internal Audit, Risk Management, and Procurement functions, as well as working closely with operational finance teams across the global businesses.

08:05 EDT Midwest Energy Emissions exercises ROFR with major US utility - Midwest Energy Emissions announced that it has exercised its right of first refusal, ROFR, for mercury emissions capture product supply with a significant coal-powered utility operating in the Midwest. This major utility entered into a license agreement with the Company in 2021 which agreement provided a ROFR with respect to certain future supply business. ME2C Environmental is exercising the ROFR and matching the terms of an offer made by another supplier for a direct three-year supply order and a renewal option, which is expected to have a value of approximately $1M annually. The utility will begin testing ME2C's SEA, or Sorbent Enhancement Additive, products in pre-supply planning discussion to determine adequate supply quantities and any sorbent tunability that may be necessary to help the utility meet the strictest mercury emissions capture and compliance requirements. The Company expects that direct supply orders for the utility's plant locations will begin in the near term during the next few months of 2022. "While we had no previous interaction with this utility prior to 2021, this utility's immediate support and swift recognition of our patented technologies for mercury emissions capture has been evident," stated Richard MacPherson, CEO of ME2C Environmental. "Within several months of announcing a license agreement with this utility that was reached in November 2021, we are excited to move toward the next phase in reaching a direct supply partnership. Adopting a strong business-first approach across the coal-fired industry has allowed us the opportunity to expand our core business organically creating positive relationships." MacPherson added, "Once direct supply orders begin by mid-year, this significant new business will be supported by the commissioning of our batch plant in Texarkana, an innovative facility that will support additional new supply business that we anticipate during 2022. As we expand our focus into new areas of growth this year, we are excited to reinforce a strong recurring revenue stream that will continue to strengthen our bottom-line."

08:03 EDT Alkami to acquire Segmint for $135.5M in cash - Alkami Technology announced it has entered a definitive agreement to acquire Segmint, a leader in making account and transaction data usable and meaningful for FIs to deepen customer relationships and grow revenues. The acquisition is expected to expand Alkami's total addressable market by approximately $1B and enable new cross-selling opportunities across a larger installed base. The transaction has been approved by the boards of directors of both companies and the stockholders of Segmint and is expected to close during the second quarter, subject to regulatory approval and customary closing conditions. Consideration will consist of $135.5M of cash payable upon closing. Based on a transaction close date of June 30, Alkami expects Segmint to contribute approximately $7M of revenue and an immaterial amount of adjusted EBITDA to its 2022 full-year financial performance. Alkami expects Segmint's annual recurring revenue under contract at December 31, 2022 to be in the range of $15M-$17M, which represents a growth rate of 30%-50% when compared to the same metric as of December 31, 2021.

08:03 EDT OncoCyte to present new data on DetermalIO at AACR annual meeting 2022 - Oncocyte announced that it will present new confirmatory data on DetermaIO, its 27-gene expression test used to identify responders to immune checkpoint inhibitor, ICI, therapies, at the American Association for Cancer Research, AACR, Annual Meeting 2022, taking place April 8-13, 2022 in New Orleans. The analysis in the poster builds on previous data, which showed that IO Score correlates with response to Genentech's Tecentriq ICI therapy for bladder cancer. The data to be presented at the AACR Annual Meeting 2022 confirm the association of the IO Score with response to ICI treatment in a second, independent, mUC cohort using the same algorithm and threshold previously established and validated in bladder and other tumor types. Launched for clinical use in Q4 of 2021, DetermaIO has demonstrated the ability to identify responders to ICIs in Lung, TNBC, and Bladder cancers, and across four approved immunotherapies - Keytruda, Opdivo, Tecentriq and Imfinzi - suggesting a potential pan-cancer and pan-immunotherapy utility in both primary and metastatic settings. Presentation Title: "1272 / 19 - Confirmatory study of the IO Score, a tumor immune microenvironment classifier, demonstrates efficacy in a real-world cohort of metastatic urothelial cancer patients treated with immune checkpoint inhibitors"

07:49 EDT enVVeno Medical expects cash to sustain operations at least through end of 2024 - The Company ended the year with $55 million in cash and cash equivalents. Based on management's current expectations, the Company believes it has sufficient cash to sustain operations at least through the end of 2024.

07:43 EDT AIM ImmunoTech announces study data on Ampligen to be presented at IHPBA - AIM ImmunoTech announced that study data evaluating the direct effects of Ampligen on human pancreatic ductal adenocarcinoma, PDAC, cells was accepted for presentation at the 15th Annual International Hepato-Pancreato-Biliary Association, IHPBA, World Congress being held March 30 - April 2, 2022 in New York, NY. Presentation title: "Rintatolimod: a potential therapeutic molecule for human pancreatic cancer cells expressing Toll-Like Receptor 3." "We are encouraged by the data demonstrated by Ampligen and its potential to offer beneficial anti-tumor effects in pancreatic cancer patients. Importantly, the direct effect of Ampligen on tumor cells and its ability to boost the anti-tumor immune response via TLR-3 present in immune cells provides the validation needed to further evaluate its potential to offer therapeutic effect to pancreatic cancer patients," commented Thomas Equels, Chief Executive Officer of AIM. For the study, three PDAC cell lines were treated with various concentrations of Ampligen and their corresponding vehicle control. The proliferation and migration effects were examined using in-vitro assays and the molecular effect was examined by targeted gene expression profiling. Additionally human PDAC samples were used to validate the expression of toll-like receptor 3 by immunohistochemistry. Results from the study demonstrated Ampligen decreased the proliferation and migration ability of CFPAC-1 cells. In addition, it decreased the proliferation of MIAPaCa-2 cells and the migration of PANC-1 cells. However, it did not have a dual effect in MIAPaCa-2 and PANC-1 cells. TLR3 was highly expressed in CFPAC-1 cells, low expressed in MIAPaCa-2 and not expressed in PANC-1. Gene expression analysis revealed the upregulation of interferon-related genes, chemokines, interleukins and cell cycle regulatory genes. The heterogeneity of TLR3 expression was confirmed in human PDAC samples.

07:41 EDT Nevakar launches ready-to-use Ephedrine Sulfate Injection - Nevakar Injectables announced the launch of its ready-to-use Ephedrine Sulfate Injection, a formulation pre-diluted to a 5mg/mL concentration and supplied in a 10mL vial. The product will be marketed and sold in the U.S. by the Par Sterile Products business of Endo International. "Ephedrine serves a very important role and is used by anesthesiologists, nurse anesthetists, and other health care professionals to treat hypotension during surgery," stated Sriram Ramanathan, MS, MBA, Chief Executive Officer of Nevakar Injectables. "Our convenient and ready-to-use Ephedrine vial fills a critical need in the marketplace by reducing the potential for dilution errors and simplifying the drug preparation process. Working together with our partners at Par, we are looking forward to additional regulatory filings, FDA approvals, and commercial launches associated with the products that Endo licensed from Nevakar in 2018," commented Ramanathan.

07:39 EDT Vitalhub announces Intouch with Health market penetration update - VitalHub announces significant growth in market penetration of UK-based subsidiary Intouch with Health. Intouch with Health has made significant headway increasing their market penetration across the United Kingdom's National Health Service, NHS. As a result of the sales closed in Q1 2022 and strong growth over the 2021 period, Intouch has achieved substantial market penetration across the NHS. Based on the 2020/2021 NHS tables, there are a total of 140 Acute Trusts in England, and Intouch has at least one module sold into 73 Acute Trusts in England, or across approximately ~52% of total sites. This compares with approximately ~42% install rate across NHS Acute Trusts in the prior year. NHS outpatient appointments totaled approximately 97,712,855 during the period, with approximately 55,170,725 or ~56.5% of total outpatient appointments being processed through the Intouch Platform. NHS outpatient attendances totaled approximately 74,808,465 during the period, with approximately 41,851,500 or ~55.9% of total outpatient attendances being processed through the Intouch Platform. This compares with 41% of all NHS outpatient attendances during the prior period.

07:37 EDT Sarcos Technology to acquire RE2 for $100M in cash, stock - Sarcos Technology announced that the company has reached a definitive merger agreement to acquire Pittsburgh-based RE2, a developer of autonomous and teleoperated mobile robotic systems for use in the aviation, construction, defense, energy and medical industries. This transaction brings together two commercial robotics teams focused on industrial robotic technologies. Consideration for the transaction is $100M, consisting of $30M in cash, which Sarcos expects to fund with cash on hand, and $70M of Sarcos common stock. Following the transaction, the shared product suite will enable the combined company to target a much broader spectrum of customer needs across the commercial and defense sectors. The initial product line will include the Guardian XO full-body, battery-powered industrial exoskeleton, the Guardian XT teleoperated dexterous mobile robotic avatar system, and the Sapien line of arms which features several models with capabilities ranging from precision arms for surgical applications, rugged outdoor arms for construction tasks, and the Sapien Sea Class system that can operate in shallow and deep water to perform inspection and maintenance tasks across multiple industries.

07:36 EDT BridgeBio to present updated results from Phase 2 OLE of AG10 - BridgeBio Pharma announced that updated data from its ongoing Phase 2 open-label extension, OLE, study of acoramidis, AG10, in patients with symptomatic transthyretin, TTR, amyloid cardiomyopathy, ATTR-CM, will be featured in an oral presentation at the American College of Cardiology, ACC, Annual Scientific Session & Expo, taking place in Washington, D.C. on April 2 - 4, 2022. Additionally at ACC 2022, BridgeBio will share an analysis on the unmet needs in care and quality of life for patients with ATTR to support the Company's ongoing research to better serve the patient community. BridgeBio's Phase 3 study investigating acoramidis in ATTR-CM is ongoing with topline data expected in mid-2023 on the Month 30 primary endpoint, which is a hierarchical composite including all-cause mortality and cardiovascular hospitalizations. BridgeBio Oral Presentation: "Long-term Safety and Tolerability of Acoramidis in Symptomatic Transthyretin Amyloid Cardiomyopathy: Updated Analysis from an Ongoing Phase 2 Open-label Extension Study." BridgeBio poster: "Unmet Needs Among Patients with Transthyretin Amyloidosis and Call for Additional Research."

07:35 EDT Biogen, Ionis Pharmaceuticals report results from Phase 1 study of BIIB078 - Biogen (BIIB) and Ionis Pharmaceuticals (IONS) announced topline results from the Phase 1 study of BIIB078, an investigational antisense oligonucleotide for people with C9orf72-associated amyotrophic lateral sclerosis. In this Phase 1 study, BIIB078 was generally well-tolerated. The adverse events were mostly mild to moderate in severity and occurred at a similar rate across BIIB078 and placebo groups. The most common AEs were fall, procedural pain and headache. BIIB078 did not meet any secondary efficacy endpoints and it did not demonstrate clinical benefit. In the dose cohorts up to 60 mg there were no consistent differences between the BIIB078 group and the placebo group. Participants in the BIIB078 90 mg dose cohort trended toward a greater decline than those in the placebo group across secondary endpoints. Based on these results, the BIIB078 clinical development program will be discontinued, including its ongoing open-label extension study.

07:33 EDT Stealth Biotherapeutics receives FDA Orphan Drug Designation for elamipretide - Stealth BioTherapeutics announced that the U.S. FDA Office of Orphan Products Development has granted Orphan Drug Designation to elamipretide for the treatment of patients with Friedreich's ataxia. A phase 2a investigator-initiated trial evaluating elamipretide for the treatment of Friedreich's ataxia has been initiated at Children's Hospital of Philadelphia under the direction of Dr. David Lynch. The trial is evaluating two doses of elamipretide in patients with Friedreich's ataxia to assess safety, visual function, and cardiac function.

07:32 EDT Provention Bio announces 'positive' results from PROVENT study of PRV-101 - Provention Bio announced positive results from the final analysis of its first-in-human PROVENT study of PRV-101, a polyvalent inactivated coxsackievirus B vaccine candidate targeting all key CVB strains associated with type 1 diabetes autoimmunity. Provention is developing PRV-101 for the prevention of acute CVB infection and its complications, as well as for the potential delay or prevention of associated autoimmune disorders T1D and celiac disease. In this final analysis, 6 months following the last dose of the vaccine, PRV-101 met the primary endpoint confirming the tolerability observed in the previously reported interim analysis, with no Treatment-Emergent Serious Adverse Events, Adverse Events of special interest, or Adverse Events leading to study drug discontinuation or study withdrawal. The results also showed durability of viral neutralizing antibody responses. At this 6-month post-final dosing time point, the percentages of subjects in the high-dose PRV-101 arm who maintained high titers of VNT were 100% for the majority of serotypes included in the vaccine and no less than 90% for all.

07:27 EDT Nordic American Tankers appoints Jenny Chu to board of directors - The company said, "Dear Shareholders and Investors, In our message of Thursday March 24, 2022, we advised you of our suggested new board member Ms. Jenny Chu. Please see enclosure for her CV. Jenny Chu has extensive experience from US capital markets and knows Nordic American Tankers for decades. Most of our ships are built in South Korea and our one million barrel Suezmaxes regularly call South Korean ports. Jenny Chu, who is an American citizen, living in Los Angeles, speaks Korean and her network in South Korea has been very valuable for NAT through the years. The experience of Jenny Chu with her knowledge of NAT, capital markets and Asia is important. She will join our board of directors now. In parallel Dallas based Doug Penick will be leaving the board to focus his attention on other business. We thank Doug Penick for his insight and contribution to the board during his tenure with NAT. We wish to continue a dialogue with Doug and draw on his comprehensive experience, in particular from Wall Street. Following these changes, there are two US citizens on the NAT board, James Kelly and Jenny Chu, one Norwegian based, Herbjorn Hansson and Alexander Hansson, the leader of our Monaco operation."

07:25 EDT Altra Industrial Motion releases inaugural sustainability report - Altra Industrial Motion announced the publication of 'Sustainability in Motion,' its inaugural Sustainability Report covering the Company's progress on environmental, social, and governance topics. The report illustrates how Altra is leveraging its core values and the Altra Business System to drive the Company's sustainability efforts forward and deliver an increasingly positive impact for all stakeholders. The report includes an overview of Altra's approach to sustainability, highlights Altra's achievements over recent years and shares insights into Altra's path forward. The topics in the Sustainability in Motion report are organized around Altra's four newly established sustainability pillars: Delivering Solutions Through Innovation - continuously innovating to develop sustainable solutions that improve performance, safety, and efficiency. Protecting The Environment - reducing Altra's environmental impact through innovative solutions and efficient operations. Reaching Our Full Potential Through Teamwork - prioritizing diversity, safety, employee engagement, and making a positive social impact to deliver long-term value to all stakeholders. Operating With Integrity - earning the trust of all stakeholders through an unwavering commitment to operating ethically and honestly.

07:23 EDT View Inc. expects to complete financial restatements in May - View, Inc. announced that it expects to complete its financial restatement and release full year 2021 and Q1 2022 results in May 2022. This includes the Company's restated 2019, 2020 and Q1 2021 financial statements, as well as its Q2 2021, Q3 2021, full year 2021 and Q1 2022 financial statements. As previously reported, the investigation of the Company's Audit Committee into its previously reported warranty accrual is now complete. While View has made substantial progress with its financial restatement and related filings, the Company now expects to complete all relevant restatement filings concurrent with the release of Q1 2022 and 2021 financial results in May 2022. To date, outside of the previously reported misstatements in warranty-related accruals, no material errors have been identified in the restatement process, which remains subject to the completion of the Company's financial close process and the completion of the financial statement audit. With the issuance of restated 2019, 2020 and Q1 2021 financial statements, as well as the filing of Q2 2021, Q3 2021, full year 2021 and Q1 2022 financial statements, View will become current on its financial filings and will regain compliance with applicable Nasdaq listing requirements. s previously reported, View is scheduled for a hearing before the Nasdaq Hearings Panel on March 31, 2022, at which the Company will present its plan to regain compliance. The Company will provide an update following that hearing and determination by Nasdaq.

07:22 EDT Uranium Royalty expands physical uranium holdings - Uranium Royalty announces that it has made additional uranium concentrate purchase commitments totaling 200,000 lbs U3O8 at an average cost of US$58.40 per pound. Deliveries will be made in April/May 2022 to URC's storage account with Cameco Corporation in Ontario, Canada. The purchase will be funded with cash on hand and available credit. With these additions, URC will hold physical uranium inventories of 1,548,068 pounds, acquired at a weighted average price of $42.20 per pound. The net realizable value of URC's existing uranium inventories has increased by approximately $25M since acquisition based on the most recent daily spot price published by TradeTech LLC, being $58.40 per pound. As previously disclosed, URC has also contracted future purchase commitments of 500,000 pounds U3O8 through 2025 at a weighted average price of $47.71 per pound.

07:21 EDT Prospect Capital says preferred stock offerings reach $600M - Prospect Capital Corporation announced that Prospect's preferred stock offerings have reached approximately $600M in aggregate liquidation preference issuances since the initial closing in the quarter ending December 31, 2020.

07:20 EDT Charles Munger gifts $1M worth of Daily Journal Corp stock to company - As part of creating additional long-term incentives for the management team while recognizing the dilution to shareholders that such incentives can cause, the company's Board of Directors has accepted Charles Munger's gracious offer to gift to the company $1 million worth of his personal Daily Journal stock for the company to use as the basis for a new equity incentive plan.

07:20 EDT McDermott's CB&I to build spheres for Plug Power's hydrogen production facility - McDermott's storage business, CB&I, will design and build two 500,000-gallon double-wall liquid hydrogen spheres for Plug Power's new green hydrogen production facility in Genesee County, New York. The production facility, leveraging Plug Power's proton exchange membrane electrolyzer technology, is expected to produce 45 metric tons of green liquid hydrogen per day-making it the largest green hydrogen facility in North America. The turnkey engineering, procurement and construction contract for both spheres also includes insulation, testing and painting with field erection taking place at Plug Power's 30-acre site at the Western New York Science, Technology and Advanced Manufacturing Park, also known as WNY STAMP. The project has passed final investment decision and is currently under construction.

07:19 EDT Daily Journal Corp appoints Steven Myhill-Jones as chairman, interim CEO - Daily Journal Corporation is pleased to announce that Steven Myhill-Jones has been selected as the company's new Chairman and Interim CEO effective. Mr. Myhill-Jones will succeed Gerald Salzman as CEO. Mr. Salzman is retiring after more than 44 years of dedicated and multi-faceted service to the company. Charles Munger will relinquish the chairman title, but will continue serving as a director, and as such will continue to pay particular attention to matters with which he has been involved in the past, including the company's securities portfolio. Myhill-Jones founded and bootstrapped web-based geography software company Latitude Geographics at the age of twenty-three. Latitude grew to a global client base of 1,400 clients-from small municipalities to Fortune 500 companies and the United Nations-before being acquired in 2017. Mr. Myhill-Jones has also been an angel investor, and an advisor and mentor to technology businesses and entrepreneurs.

07:16 EDT Brunswick appoints Alexandra Cattelan as CTO - Brunswick Corporation (BC) announced that it has appointed Alexandra Cattelan as its Chief Technology Officer, effective immediately. Cattelan will be responsible for continuing to advance Brunswick's ACES strategy and, more generally, for maintaining Brunswick's position of technology leadership in the marine industry. Cattelan most recently served as Vice President, Engineering, Connected, Controls, Electrification and Autonomous Systems for Polaris Industries (PII).

07:14 EDT Digihost expects to increase hashrate to 1.5EH in 2022 - In 2021, the Company had adjusted EBITDA of $14.01 million and operated at an average hashrate of approximately 275PH. Upon full deployment of the 10,600 BTC miners now delivered and received, the Company anticipates increasing its hashrate to approximately 1.5EH in 2022, approximately 5.5 times the Company's average hashrate of 275PH in 2021. At its current computing power of 720PH, the Company is generating approximately 3.35 BTC per day which would result in a production rate of approximately 6.7 BTC per day at an anticipated computing power of 1.5EH, based upon current network difficulty. Digihost is currently able to leverage its existing workforce to reach increased production levels without incurring additional costs, thereby decreasing the Company's SG&A expenses as a percentage of total revenue. Another critical success factor in Digihost's strategic growth plan is access to clean sources of energy and on-demand program, interruptible power with utilities which will allow Digihost the ability to provide urgent power needs for local communities during extreme weather conditions. During 2021, the Company launched its DigiGreen initiative, an industry-leading plan to reduce the Company's already low carbon footprint by operating its business in an environmentally and socially responsible way. Currently, over 90% of the energy consumed by the Company in its BTC mining operations is from sources that create zero carbon emissions. During 2021, the Company entered into a binding agreement for the purchase of a 60MW independent power project in upstate New York. The power facility has the capacity to accommodate approximately 17,000 new BTC miners. To-date, all required permits from the city of North Tonawanda, NY have been received and the Company is currently awaiting receipt of Public Service Commission approval to close the acquisition. The Company has completed significant infrastructure installation work on site at the facility and is currently running uninterrupted mining operations as it works toward completing the deployment of additional miners. The Company continues to pursue opportunities for expansion and vertical integration of clean sources of energy and has several initiatives it is currently pursuing.

07:13 EDT Southwest Gas urges shareholders to vote on the WHITE proxy card - Southwest announced it is mailing a letter to its stockholders in connection with its upcoming Annual Meeting of Stockholders scheduled for May 12. The letter highlights that stockholders should vote FOR ALL the Board's nominees on the WHITE proxy card in order to benefit from the transformation of Southwest Gas and the value unlocked by the spin-off of Centuri.

07:12 EDT HCW Biologics expects cash to fund operations until end of 2023 - On December 31, 2021, the Company's cash balance was $11.7M , short-term investments were $25M and long-term investments were $9.9M. The net proceeds from the IPO were $49.2M. The Company estimates that it has sufficient cash to fund operation expenses to the end of 2023. This estimated cash runway does not include potential sources of non-dilutive financing, which may be obtained from new or existing out-licensing agreements.

07:11 EDT GH Research expects cash to fund operating expenses into 2025 - Cash was approximately $273.8 million as of February 28, 2022, and we believe that our existing cash will be sufficient for us to fund our operating expenses and capital expenditure requirements into 2025.

07:10 EDT Protagonist Therapeutics names Asif Ali as CFO - Protagonist (PTGX) announced the appointment of Asif Ali as Executive Vice President and CFO. In this role, Asif's responsibilities will extend across all finance-related functions within the company, including financial planning and analysis, taxation, accounting and financial reporting, finance operations, investor relations, and strategic partnership-related financings. Asif will join Protagonist in mid-April. He comes to Protagonist from Theravance Biopharma (TBPH), where he served as Chief Accounting Officer.

07:08 EDT Terran Orbital begins trading on NYSE - Terran Orbital announced that its common stock and warrants will begin trading on the New York Stock Exchange on March 28 under the ticker symbols "LLAP" and "LLAP WS", respectively.

07:05 EDT PayPal broadens access to post purchase services for merchants - PayPal (PYPL) announced it is delivering more ways to help retailers manage returns by enabling merchants who offer PayPal Checkout to use the Happy Returns return and exchange portal software at no additional cost. Additionally, the company has partnered with Ulta Beauty (ULTA) which increases the total number of Happy Returns Return Bar locations to more than 5,000. As online shopping has continued to accelerate during Covid, average return rates have increased to more than 20%, making it more important than ever for merchants to manage their post-purchase processes more effectively.

07:03 EDT Bitfarms provides 2022 expansion plan update - The Company believes its existing orders of miners and contracted infrastructure expansion have the potential to produce approximately 7.2 EH/s by the end of 2022, based upon the current facility development and deployment schedule that includes the construction of two warehouse facilities in Rio Cuarto, Argentina, currently expected to be operational in December 2021. The Company continues to develop opportunities, including additions and alternatives to its currently contracted infrastructure expansion, to reach its 8.0 EH/s target by year-end. Achievement of these targets is dependent on meeting construction timelines and sourcing of supplies. "As we develop our farms, we assess the cost effectiveness of our expansion on an ongoing basis. In Argentina, we are reviewing the short-term and long-term impact of higher global energy prices witnessed since the start of 2022 and our ability to utilize up to 210 megawatts of infrastructure capacity in 2022 at previously anticipated rates," noted Geoff Morphy. "Opportunities are being assessed continually in all of our current geographic regions to implement cost effective growth in light of market conditions," added Morphy.

07:03 EDT Talos Energy receives final UR from SENER for Zama field development - Talos Energy announced that it has received the final Unitization Resolution, or UR, from Mexico's Ministry of Energy, or SENER, regarding the development of the Zama field in offshore Mexico. Among other things, the UR affirms the appointment of Petroleos Mexicanos as operator of the unit. Unitization of the Zama field was required after determination that the field is located within both the Talos-operated Block 7 and an adjacent Pemex-operated block and provides for joint development of the entire reservoir instead of each party developing its own block. Talos will maintain a 17.35% participating interest in the Zama field, and the company anticipates submission of a Unit Development Plan for approval by the working interest partners within 6-12 months, a critical step before the parties can make a Final Investment Decision in 2023. Talos will participate in activities related to reaching FID, while also continuing to evaluate various strategic and legal options. The company does not expect any material changes to its 2022 capital expenditures guidance as a result of the issuance of the UR. Talos, as operator and 35% partner in the Block 7 lease, discovered the Zama field in 2017 as the first private sector consortium to enter Mexico following the country's major energy reforms. Zama was subsequently named the 2017 Global Discovery of the Year by Wood Mackenzie, and the field was fully appraised by mid-2019. An independent third-party reserves auditor estimated the discovered recoverable resource volumes to be between approximately 735M-950M barrels of oil equivalent, and Zama could produce over 160,000 barrels of oil equivalent per day once fully developed. Talos has invested approximately $104M in Zama since 2015 and these past investments are subject to cost recovery under the production sharing contract.

07:02 EDT Southwest Gas board rejects Carl Icahn's unsolicited tender - The company states: "Southwest Gas Holdings announced that its Board of Directors, following a thorough review with the assistance of its financial and legal advisors, has unanimously determined that the revised tender offer from an affiliate of Carl Icahn to acquire any and all outstanding common shares of the company for $82.50 per share in cash is inadequate, structurally coercive, highly conditional, undervalues the company, and is not in the best interests of all of its stockholders. Accordingly, the Board recommends that stockholders not tender any of their shares into the Offer. On November 9, 2021, the Board rejected Mr. Icahn's initial unsolicited tender offer of $75.00 per share."

06:52 EDT MAG Silver CFO Larry Taddei steps down, Fausto Di Trapani succeeds - MAG Silver pleased to announce the appointment of Fausto Di Trapani as CFO, effective May 20. Fausto replaces Larry Taddei, who, after 12 years of service with the company, will step down from the CFO role to pursue other opportunities. Larry will assist in the orderly transition of his duties following Fausto's appointment. Fausto is a finance executive with experience in the natural resources sector spanning two decades. He has held progressively senior finance roles with BHP Billiton, Norilsk Nickel and Mantra Resources. Most recently, Fausto served as the CFO at Galiano Gold.

06:37 EDT Sanofi reports Xenpozyme approved in Japan for acid sphingomyelinase deficiency - The Japanese Ministry of Health, Labor, and Welfare, or MHLW, has granted marketing authorization for Xenpozyme for the treatment of adult and pediatric patients with non-central nervous system manifestations of acid sphingomyelinase deficiency, or ASMD, a rare, progressive, and potentially life-threatening genetic disease, Sanofi announced. "Xenpozyme is currently the only approved treatment for ASMD and represents Sanofi's first therapy to be approved under the SAKIGAKE or 'pioneer' designation, which is the Japanese government's regulatory fast-track pathway to promote research and development of innovative new medical products addressing urgent unmet medical needs," the company said.

06:34 EDT GE Healthcare: First patient dosed in Phase 3 PET radiopharmaceutical trial - GE Healthcare has announced the first patient dosed in the Phase III clinical trial for a Positron Emission Tomography radiopharmaceutical imaging agent which aims to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care. Already a global leader with DaTscan, used in Single-Photon Emission Computed Tomography imaging across more than 40 countries worldwide, GE Healthcare is now planning to bolster its portfolio with two pipeline radiopharmaceuticals, one for PET and one for SPECT. This multi-center Phase III clinical trial of a PET radiopharmaceutical is underway in France. In addition to offering a potentially shorter patient workflow, the clinical trial is comparing PET for striatal dopamine transporter visualization with DaTscan. PET technology offers higher spatial resolution than SPECT, which may result in a clearer image to aid visual interpretation and diagnosis. This PET radiopharmaceutical was originally developed by Zionexa, a French company specializing in innovative radiopharmaceuticals which was acquired by GE Healthcare's Pharmaceutical Diagnostics business last year.

06:30 EDT Scorpio Tankers to sell three vessels - Scorpio Tankers announces that the company has entered into agreements to sell three vessels, two LR2s and one MR. The sale price of the two LR2s is $86M in aggregate, and the sale price of the MR is $26.5M. Scorpio Services Holding Limited, a related party, owns a non-controlling 7.50% interest in the buyer of STI Benicia. The company is expected to raise additional liquidity of approximately $55M from these transactions, which are expected to close in the second and third quarters.

06:10 EDT Vermilion Energy raises FY22 production view to 86,000-88,000 boe/d - The company said, "Vermilion is increasing its 2022 E&D capital budget to $500 million and increasing its annual production guidance to 86,000 to 88,000 boe/d to account for the Leucrotta acquisition, assuming a second half of May 2022 closing date. With the execution of the planned Mica drilling program and the anticipated close of the Corrib acquisition in second half 2022, we expect to exit the year with corporate production in the range of 95,000 to 100,000 boe/d. Our intention is to maintain the production base in this range for the foreseeable future as we focus on high grading and optimizing our portfolio inventory in order to maximize free cash flow generation over the long-term. The Leucrotta acquisition aligns with our long-term value driven acquisition strategy which targets underexploited consolidation opportunities in core areas with multi-zone development. This acquisition is expected to enhance our North American portfolio by adding an inventory-rich land base in the Montney, providing decades of drilling inventory that we will high-grade as we grow our production base and further strengthen our free cash flow profile. The combination of the Corrib acquisition and the Leucrotta acquisition will allow us to maintain our geographic diversification. On a pro forma basis, including both acquisitions, we expect our international production and FFO weighting to be approximately 36% and 58%, respectively. This diversification, which provides exposure to global commodity prices, has afforded us the ability to fund both of these transactions, with internally generated free cash flow in 2022. Inclusive of the Leucrotta acquisition, we have announced in excess of $1.2 billion of acquisitions equally balanced between international and North America in 2021 and 2022 without issuing any equity. As a result of our strong near-term FCF generation, combined with our profitable inventory to support this FCF profile for years to come, we remain on track to meet our net debt targets and enhance our return of capital strategy. We continue to anticipate reaching our $1.2 billion debt target in 2H 2022, which implies a leverage ratio less than 1.3x at mid-cycle prices(3), and will look to increase our return of capital once we achieve this target. The intended incremental return of capital may come in the form of an increase to the quarterly dividend, share buybacks, special dividends or any combination thereof. The revised guidance does not include any contribution from the Corrib acquisition. We continue to anticipate the Corrib transaction closing in 2H 2022 and will revise our formal guidance at that time. As a reminder, all interim free cash flow from the acquired Corrib interest is being accrued to Vermilion and will be netted from the final purchase price. Based on the forward commodity strip(4) and including the Leucrotta acquisition, we estimate pro forma FFO of $2.4 billion and FCF of $1.9 billion, with year-end net debt of $0.9 billion and a trailing net debt to FFO ratio of 0.4x."

06:07 EDT Centerra Gold provides update on negotiations with Kyrgyz government - Centerra Gold issued the following statement: "Centerra Gold Inc. notes that the Cabinet of Ministers of the Kyrgyz Republic has approved a decision by the Kyrgyz Government to conclude an agreement with Centerra related to Centerra's Kumtor Mine, as reported by Kyrgyz news media. Negotiations with representatives of the Kyrgyz Government and Kyrgyzaltyn JSC continue with a view to finalizing a transaction that Centerra expects will include the principal terms outlined in the Company's press release dated January 3, 2022. As previously disclosed, Centerra expects that the framework for any transaction will include exchanging Centerra's interest in the Kumtor Mine for, among other things, Kyrgyzaltyn JSC's Centerra common shares, as well as full and final releases of all claims of the parties and termination of all legal proceedings involving the parties in all jurisdictions with no admissions of liability. Processes in respect of the foregoing and other matters required in connection with an acceptable transaction remain outstanding. Accordingly, there can be no assurance that any proposed transaction will be agreed to or consummated or as to the final economic and other terms and conditions of any such transaction, if agreed."

06:05 EDT Cyberoptics receives $1.9M order for 3D MX3000 systems - CyberOptics announced that it has received an order valued at $1.9M from a recurring customer for its 3D MX3000 memory module inspection systems, powered by Multi-Reflection Suppression sensors. These final vision inspection systems are expected to be recognized as revenue in the second half of 2022.

06:03 EDT Jazz Pharmaceuticals to divest Sunosi to Axsome Therapeutics for $53M upfront - Jazz Pharmaceuticals (JAZZ) announced that it has entered into a definitive agreement to divest Sunosi, a dual-acting dopamine and norepinephrine reuptake inhibitor shown to improve wakefulness in adults living with excessive daytime sleepiness, or EDS, due to narcolepsy or obstructive sleep apnea, to Axsome Therapeutics (AXSM). Under the terms of the agreement, Axsome will receive the rights to Sunosi in all of the existing territories available to Jazz. Jazz will receive financial terms including an upfront payment of $53M, a high single-digit royalty on Axsome's U.S. net sales of Sunosi in current indications and a mid-single-digit royalty on Axsome's U.S. net sales of Sunosi in future indications. The divestiture of Sunosi to Axsome will enable Jazz to sharpen its focus on its highest strategic priorities designed to deliver sustainable growth and enhanced shareholder value. In assessing the positioning of Sunosi in the overall treatment landscape, Jazz determined Axsome would be well positioned to deliver access to this important medication and to maximize the value of Sunosi to Jazz through future growth. Sunosi's consistent positive feedback from patients, HCPs and providers is underscored by its efficacy. Jazz and Axsome are committed to ensuring that patients receive uninterrupted access to Sunosi throughout the transition.

05:44 EDT Chase launches new saver account for UK customers - Chase has launched a new savings option for UK customers. The Chase saver account, which is linked to the Chase current account, will offer savers a rate of 1.5% AER. Available to all new and existing Chase current account holders, the saver account is available via the Chase app with round the clock support led by Chase's UK customer support team. Customers can open multiple saver accounts to suit their savings goals. E

05:35 EDT Heineken announces decision to leave Russia - Heineken said in a statement: "We are shocked and deeply saddened to watch the war in Ukraine continue to unfold and intensify. We earlier announced that Heineken stopped new investments and exports to Russia, ended the production, sale and advertising of the Heineken brand, and announced that we will not accept any net financial benefits or profit from our business in Russia. Following the previously announced strategic review of our operations, we have concluded that Heineken's ownership of the business in Russia is no longer sustainable nor viable in the current environment. As a result, we have decided to leave Russia." Reference Link

05:27 EDT Galapagos reports Gilead, Eisai get MHLW approval for second Jyseleca indication - Galapagos (GLPG) reported that Gilead Sciences K.K. (GILD), Eisai (ESALY) and EA Pharma announced the approval by the Japanese Ministry of Health, Labour and Welfare, or MHLW, of a second indication for Jyseleca, a once-daily, oral, JAK1 preferential inhibitor, for the treatment of patients with moderate-to-severe active ulcerative colitis.

05:20 EDT Staar Surgical receives FDA approval for EVO - Staar Surgical announced that the FDA has granted approval of the EVO/EVO+ Visian Implantable Collamer Lens, or EVO for the correction of myopia and myopia with astigmatism. Myopia, which is also known as nearsightedness or the need for distance vision correction, is the most common vision disorder globally.

05:10 EDT New Oriental Education to implement ADS to common share ratio change - New Oriental Education announced that it plans to change the ratio of its American Depositary Shares, or ADSs, to its common shares, par value $0.001 per share, from the current ADS Ratio of one ADS to one common share to a new ADS Ratio of one ADS to 10 common shares. A post-effective amendment to the ADS Registration Statement on Form F-6 will be filed with the SEC to reflect the change in the ADS Ratio. The company anticipates that the change in the ADS Ratio will be effective on or about April 8, subject to the effectiveness of the post-effective amendment to the ADS Registration Statement on Form F-6 on or before that date. For New Oriental's ADS holders, the change in the ADS Ratio will have the same effect as a one-for-ten reverse ADS split. Each ADS holder of record at the close of business on the date when the change in ADS Ratio is effective will be required to surrender and exchange every ten existing ADSs then held for one new ADS. No fractional new ADSs will be issued in connection with the change in the ADS Ratio.